Elsevier announces its intention to acquire Interfolio
London, April 21, 2022
Elsevier, a global leader in research publishing and information analytics, and part of RELX, announced today that it has entered into an agreement to acquire Interfolio, a provider of advanced faculty information solutions for higher education, headquartered in Washington DC, US.
Founded in 1999, Interfolio supports over 400 higher education institutions, research funders and academic organizations in 25 countries, and over 1.7 million academic professionals and scholars.
Theo Pillay, General Manager of Research Institutional Products, Elsevier, said: “Interfolio has a proven track record in supporting the academic community, thanks to its deep understanding of faculty needs, institutional workflows, research assessment and academic careers, combined with its agile technology and experienced leadership. Together, we aim to deliver even greater value to customers through improved user experiences, such as reducing the time researchers spend entering data with better automation and providing deeper insights with more sophisticated analytics tools. I look forward to welcoming the Interfolio team to Elsevier.”
Interfolio will be part of Elsevier’s Research Intelligence portfolio, which delivers analysis and insights to help academic researchers, research leaders, institutions and funders achieve their strategic goals. Together, our products and solutions support each step of the research process, from developing strategy, securing funding, to showcasing and evaluating research outputs, outcomes and impacts.
The transaction is subject to customary conditions and regulatory consents and is expected to close during Q2 2022.
Conceived by academics for academics, Interfolio is an education technology company headquartered in Washington, DC, US. Founded in 1999, Interfolio serves colleges and universities, funders and research organizations, and individual scholars. More than 400 clients based in 25 countries choose Interfolio’s solutions for hiring and recruitment, academic appointments and timelines, activity data reporting, faculty reviews and promotions, and research impact analysis. Interfolio provides scholar-first products for the full academic lifecycle—from job seeking to professional accomplishments, committee service, funding award compliance, career growth and advancement, administrative leadership, and beyond. For more information about Interfolio, please visit www.interfolio.com
RELX is a global provider of information-based analytics and decision tools for professional and business customers. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs more than 33,000 people over 40% of whom are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York stock exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalisation is approximately £46.6bn/ €55.8bn/ $60.7bn.
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.
In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.
Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.